Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection
PROJECT LEADER
TEAM MEMBERS
Joseph, PK (Mr Philip)
Department
Research Outputs
- Whole person HIV services: a social science approach
- Daily Oral Pre-exposure Prophylaxis (PrEP) continuation among women from Durban, South Africa, who initiated PrEP as standard of care for HIV prevention in a clinical trial
- High levels of pretreatment HIV-1 drug resistance mutations among South African women who acquired HIV during a prospective study